The rise of Viagra initially drove a surge for major pharmaceutical companies, but recent changes present a complicated picture for investors. Generic versions are reducing profits, and ongoing litigation add https://bronteyxpb248923.blogolenta.com/38222861/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-investment